HMGA2 and breast neoplasm: A possible explanation is that the complex CtIP(CtTB interacting protein)/ZNF350/BRCA1 complex represses the expression of angiopoitin-1 (ANG1) and high-mobility group AT-hook 2 (HMGA2), which are commonly involved in the proliferation and vascular formation of breast tumours [17, 18].